In the current pTNM classification system, nodal status of breast cancer is based on the number of involved lymph nodes and does not account for the total number of lymph nodes removed. In this study, we assessed the prognostic value of the lymph node ratio (LNR; ie, ratio of positive over excised lymph nodes) as compared with pN staging and determined its optimal cutoff points.
INTRODUCTION
Axillary lymph node involvement and the number of involved axillary lymph nodes are among the most important prognostic factors in breast cancer.
1,2 The number of involved axillary nodes has been incorporated into routine clinical decision making, [3] [4] [5] and according to the sixth edition of the American Joint Committee on Cancer/International Union Against Cancer staging system, patients with one to three positive axillary lymph nodes are classified as having pN1 disease, patients with four to nine positive axillary lymph nodes are classified as having pN2 disease, and patients with 10 or more positive axillary lymph nodes are classified as having pN3 disease. [6] [7] [8] The number of involved lymph nodes identified depends on the number of lymph nodes removed and examined, which in itself depends on the surgical and pathologic procedure. In these cases with few nodes removed, patients cannot be classified as having pN3 disease, which can affect comparisons between institutions where the practices of axillary dissection differ. To improve the prognostication system, one would intuitively take not only the number of positive lymph nodes, but also the number of nodes examined into account. 9 The lymph node ratio (LNR), defined as the number of involved nodes divided by the number of lymph nodes examined, standardizes against the variability of nodal assessment and was found to improve prognostic information when compared with the number of involved nodes. Woodward et al 10 conducted a systematic review of 24 articles published between 1994 and 2005 totaling 32,299 patients, of whom 3,565 were from four randomized trials, and 18,038 patients were from a Surveillance, Epidemiology, and End Results study. The LNR was confirmed to be superior to the number of involved nodes as a prognostic indicator. A subsequent study comparing patients included in prospective trials showed that the LNR improved the comparability of institutions.
11 However, to date, there has been no formal proposal toward using the LNR as an alternative to the current pN staging. Moreover, a robust and reproducible categorization can be important to identify subgroups of patients who might better respond to a treatment or to efficiently plan prospective trials. Hence we will address in this article whether patients with breast cancer can be classified into meaningful risk categories based on LNR, by comparing it with pN staging.
PATIENTS AND METHODS
We used data from the Geneva cancer registry, which records information on all incident cancer cases that occur in the canton (approximately 420,000 inhabitants). The registration is based on several sources of information and is accurate, as attested by its low percentage (Ͻ 2%) of cases recorded from death certificates only.
12
Information recorded for each patient includes sociodemographic data, diagnostic circumstances, diagnostic modalities, histologic features of the tumor, treatment during the first 6 months after diagnosis, survival, and cause of death. In addition to passive follow-up (routine examination of death certificates and hospital records), the registry regularly assesses survival through an active follow-up performed routinely each year at the Cantonal Population Office, which is in charge of the registration of the resident population. For all deceased patients, the registry's medical staff systematically consults medical files, writes to practitioners to assess the exact cause of death, and codes the cause according to the WHO classification.
13
This study included all female residents of the Swiss canton of Geneva with a nonmetastatic primary invasive breast carcinoma diagnosed between 1980 and 2004 (n ϭ 6,936). We selected women who underwent axillary lymph node dissection, in whom the total number of nodes examined was mentioned in the pathology report (n ϭ 5,053), and who presented with one or more involved (ie, positive) lymph nodes (n ϭ 1,924 after exclusion of 2,954 node-negative cases and 175 cases with an unknown number of positive nodes). We excluded records in which tumor size was not reported (n ϭ 95). The final number available was 1,829 patients, representing the study population. A separate coding for the sentinel node procedure was introduced in 2001; the selection did not retain 118 cases of positive sentinel nodes because of missing total number of nodes.
We considered sociodemographic characteristics, tumor characteristics, and treatment covariates for the models. Sociodemographic variables were age (continuous), and year of diagnosis (continuous). Economic status was based on the woman's most recent occupation, or that of the spouse for the unemployed, and was categorized as high (professionals, executives, and administrators) versus lower classes. Histologic features considered were grade (poorly or undifferentiated v others), log of tumor size in centimeters (continuous), number of nodes removed (continuous), number of positive nodes (continuous), and LNR (continuous). Adjuvant treatments considered were radiotherapy of breast or chest wall (yes/no), chemotherapy (yes/no), and hormone therapy (yes/no). End point for the survival analyses was death from breast cancer. Patients who died from other causes were censored at the time of death. Patients who left the canton were censored at the last date of known residence.
The analysis was done in two stages. In the first stage, we evaluated the prognostic value of LNR, adjusting for other above-mentioned covariates significantly associated with breast cancer mortality. With Cox proportional hazards analyses, we calculated breast cancer-specific mortality risks. We applied the Akaike Information Criteria (AIC) to identify the covariates that were the most significantly associated with mortality and to prevent overadjustment.
14 We used no other criteria. In the second stage, after ascertaining that the LNR was indeed significantly associated with breast cancer mortality, we proceeded to determine the most appropriate cut point for categorizing LNR as high risk, medium risk, and low risk. For this, we recomputed the likelihood associated with all possible pairs of LNR cutoffs (dividing patients into high-, medium-, and low-risk categories) ranging from 0.05 to 0.95 at intervals of 0.05. 15 We recorded the differences between the likelihoods of the cutoff models (where the LNR was categorized by the cut points) and the AIC model (where the LNR was modeled as a continuous covariate). We retained the pair of cutoffs associated with the least negative difference in likelihoods (ie, the pair causing the least loss of information resulting from categorization).
To estimate the stability of the results, we used a bootstrap procedure, 14,16 which applies the proportional hazards computations to full random samples with replacement of the patients. We ran 10,000 iterations of the procedure.
We also examined the impact of specifying a minimum number of lymph nodes excised on the accuracy of the LNR by recomputing the hazard ratios for different minimum numbers of lymph nodes excised.
The study was not submitted to an internal review board but was developed through consensus meetings within the registry. All statistical computations used R version 2.6.1. 17 The AIC procedure used the MASS library. 18 The likelihood profiles were smoothed using the "mgcv" package. 
RESULTS
The median age of the 1,829 patients was 58.9 years ( Table 1) . The number of patients in the last 5 years decreased as a result of the separate coding of sentinel node procedure and corresponding missing cases. A large majority of patients (81%) had at least 10 axillary lymph nodes removed. The median number of involved nodes was two (range, one to 32 nodes), and the mean LNR was 0.18 (range, 0.016 to 1.000). Most patients (90%) had received radiotherapy, chemotherapy, or hormone therapy, alone or in combination.
In the first stage of multivariate analyses, patients' age, year of diagnosis, grade, size, radiation treatment, chemotherapy, endocrine therapy, and LNR were independent and significant prognostic factors of breast cancer mortality (Table 2) . LNR as a continuous covariate was the most important prognostic factor, with a 4.51-fold increased relative risk, with LNR expressed on a fractional scale from 0 to 1, corresponding to a relative breast cancer mortality increase of 1.5% per 1% involved nodes, with LNR expressed on a percentage scale. Socioeconomic class and tumor location in inner quadrants were not statistically significantly associated with breast cancer mortality (Table  2) . Nevertheless, these two variables contributed to improve the AIC and were therefore retained in the model. The number of positive nodes was not retained. Examination of 10,000 resamplings of the data with reiterations of the AIC selection showed that the LNR was retained in 99.98% of the random samples, whereas the number of removed nodes and the number of positive nodes were retained respectively in only 76.38% and 26.39% of the random samples.
In the second stage, we used the multivariate model as identified in Table 2 , but iteratively replacing the continuous LNR with different pairs of categorized LNRs. Figure 1 summarizes the distribution histograms of the LNR cutoff points that were associated with the least negative change of maximum partial likelihood based on 10,000 bootstrap iterations. The figure indicates the number of times any given cutoff point was retained. The distribution histograms show a sharply defined lower LNR cutoff point of 0.20 (mean, 0.21; standard deviation, 0.04; 95% CI, 0.15 to 0.30; Fig 1A) and an upper LNR cutoff point of 0.65 (mean, 0.67; standard deviation, 0.13; 95% CI, 0.30 to 0.95; Fig  1B) . The presence of a separate smaller peak (Fig 1B) indicates that in some random samples, the upper cutoff point was very close to the lower cutoff point, but this occurred only in 5% of the samples.
Using the pair of cutoff points of 0.20 and 0.65, we classified patients with LNR Յ 0.20 into low-risk, LNR more than 0.20 and Յ 0.65 into intermediate-risk, and LNR more than 0.65 into high-risk categories. Figure 2 shows the univariate Kaplan-Meier survival estimates according to risk groups defined by pN staging (Fig 2A) or defined by the LNR (Fig 2B) . The breast cancer-specific survival at 10 years for patients with low-risk, intermediate-risk, and high-risk LNR were 75.2%, 63.3%, and 39.6%, respectively (log-rank 2 ϭ 155.7). In addition, the pN classification showed an imbalance in prognostic separation, with the pN2 and pN3 survival curves crossing after 15 years, whereas the nodal-ratio curves remained separated, even with a follow-up exceeding 20 years (Fig 2) . In multivariate analysis, compared with patients within the low LNR risk group, the adjusted hazard ratio of breast cancer mortality risk was 1.78 (95% CI, 1.46 to 2.18) for patients in the intermediate LNR risk group and 3.21 (95% CI, 2.54 to 4.06) for patients within the high LNR risk group (Table 3) . By comparison, the survival rates for patients with pN1, pN2, and pN3 disease were 75.8%, 54.4%, and 42.7%, respectively ( 2 ϭ 150.5). Compared with patients with pN1 stage, the adjusted hazard ratio of breast cancer mortality was 2.07 (95% CI, 1.69 to 2.53) for patients with pN2 stage and 2.84 (95% CI, 2.23 to 3.61) for patients with pN3 stage (Table 3 ). The CIs of the pN2 and pN3 hazard ratios overlapped, in contrast with the LNR hazard ratios, which did not overlap.
We looked at the impact of specifying a minimum number of excised lymph nodes on the reliability on the pN and the LNR hazard ratios, respectively. Figure 3 shows the hazard ratios from the same multivariate model as in Table 3 , recomputed each time by successively excluding patients with fewer than one-then two, three, and so on-lymph nodes excised. The overlapping of the pN CIs was not improved by specifying a minimum number of lymph nodes to be removed (Fig 3A) . The LNR CIs remained separated, up to 13 excised lymph nodes (Fig 3B) . In both pN and LNR cases, the width of the CIs increased, indicating loss of precision with more stringent minimum specification.
DISCUSSION
In this study, the LNR was one of the most important prognostic factors of breast cancer mortality. The LNR provided a better classification of patients' prognostic risk profile than the pN classification system, in particular after 10 years. Also, this study proposes, for the first time, a categorization of the LNR validated by bootstrap resampling among a population-based cohort of women with lymph nodepositive breast cancer.
There is growing evidence establishing the prognostic role of the LNR in breast cancer.
9-11, [20] [21] [22] The importance of the LNR has been shown for many cancer sites from the Surveillance, Epidemiology, and End Results population data: esophagus, 23 20 and 0.25/0.50/0.80. 37 We tried to identify cutoff points that should be robust against the variability of the data. Hence we chose the bootstrap resampling method, which does not necessarily rely on P values or distributional assumptions. 38, 39 We found that the lower cutoff point was sharply defined with a narrow CI, suggesting high reliability. The value of 0.20 closely matches the most recent reports from other centers. 10, 11, 21, 22 Interestingly, the upper cutoff point was less sharply defined. The wider CI is attributable to the smaller number of patients with a high LNR. But it also suggests an increased heterogeneity among patients with more extensive nodal involvement. 40 Categorization of a continuous variable (in our case, the LNR) has been shown to be associated with several problems, including loss of information, 38,41,42 inflation of type I error rate, 43 increase in variance of estimated hazard ratios, loss of power, and decrease in efficiency of survival analysis 44, 45 and can even mislead one into concluding that a second unimportant variable is important. 46 In the present study, we built the model with LNR as a continuous variable. Categorization was done afterward. In examining the output of the bootstrap iterations, which generated 1.67 million comparisons between the continuous LNR and the various categorized LNR models, we found that the categorized models were poorer than the continuous models in 89.8% of the comparisons, confirming that the LNR should be maintained as a continuous covariate for modeling purposes. However, these reasons do not preclude the need for categorization, which can arise because of the complexity of underlying computations, as discussed hereafter. We used a scale from 0 to 1 for the LNR, which gave a hazard ratio of 4.51. The LNR is linear in the logarithm of the hazard ratio. To compute, for example, the relative risk of breast cancer death associated with the involvement of one node of five nodes total, as compared with no nodal involvement, we need to convert the hazard ratio into its corresponding regression coefficient, 1.506 ϭ Log(4.51), multiply this coefficient by 0.20 (ϭ 1/5), which gives 0.301 (ϭ 1.506 ϫ 0.20), then exponentiate to obtain a hazard ratio of 1.35 ϭ Exp(0.301). This need to switch back and forth between logarithm and exponentiation is awkward for daily clinical practice, it cannot be obviated by changing the scale, and it can be prone to misinterpretation. By contrast, hazard ratios of categorized LNR such as those shown in Table 3 are immediately readable.
Our categorization of the LNR showed a clear advantage over pN staging: the 3.21 hazard ratio of the high-risk LNR indicates a separation between the high-and low-risk group (3.21 Ϫ 1 ϭ 2.21) that is wider than the separation between pN3 (hazard ratio ϭ 2.84) and pN1 (2.84 Ϫ 1 ϭ 1.74). Moreover, the intermediate-risk LNR was truly intermediate; its CI overlapped neither the low risk nor the high-risk LNRs, whereas the pN2 and pN3 CIs overlapped (Table 3) . Thus in multivariate analyses, classification using the LNR provided wellbalanced nonoverlapping risk groups, whereas classification using pN provided poorly separated risk groups with overlapping hazard ratios.
The advantage of the LNR classification over pN staging was also apparent in unadjusted survival analysis. The log-rank 2 associated with the LNR was larger than that of pN (Fig 2) , indicating a higher statistical significance. The LNR provided a balanced separation between the survival curves. The survival curves of the three LNR curves did not cross, even with a follow-up exceeding 15 years. By contrast, the survival curves of the pN risk groups were unbalanced. The pN2 and pN3 curves were close to one another and crossed, indicating graphically a poorer separation between intermediate-and high-risk groups (Fig 2A) .
The question arises whether LNR-based classification should replace pN classification. For homogeneous data-if, for example, all patients underwent the same extensive axillary dissection-the distinction between a number-based and a ratio-based staging would disappear, and there would be no advantage of replacing the pN with an LNR-based classification. However, heterogeneity of lymph node examination is commonly encountered in daily practice; the LNR can be useful to address that heterogeneity. Our present population study found that the LNR improved over the pN. The improvement was observed in both multivariate and univariate analyses. In prospective randomized clinical trials, we believe that it would be more meaningful to balance patients allocation using the LNR-based risk groups rather than the pN. Taking into account that other authors have reported that the LNR also improved the comparison between centers, 11 our results argue that the LNR should be considered as an alternative to pN staging.
We acknowledge several limitations. We need additional studies on different populations and other health systems to validate our results and generalize our conclusions. The LNR assumes all lymph nodes are similarly examined, an unlikely condition. Our modeling did not account for the size of nodal metastases or factors like extracapsular or vascular invasion. We did not address supraclavicular or internal mammary chain involvement. The analyses were restricted to patients with measurable primary tumors. Furthermore, as sentinel node biopsy is progressively replacing axillary lymph node dissection, the value of the LNR becomes questionable.
Strengths of this study are the population basis and accurate follow-up data. Regarding the sentinel node biopsy, a growing literature indicates that the ratio of involved sentinel nodes and the proportion of sentinel nodes replaced by metastasis are important predictors of nonsentinel node involvement. [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] Our results blend with these concepts of tumor load in the sentinel nodes. We believe that LNRbased staging might provide a smooth transition toward biomarkerbased staging in the near future, such as hinted by the gene recurrence score 57 or circulating tumor cells.
58,59
In conclusion, our study identifies two LNR cutoff points, 0.20 and 0.65, which define breast cancer prognosis more adequately than the pN categories. We argue that nodal ratios should be considered as an alternative to pN staging. 
